查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768823

全球連網藥物傳輸設備市場

Connected Drug Delivery Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球連網藥物輸送設備市場規模將達到 255 億美元

全球連網藥物輸送設備市場規模預計在2024年為79億美元，預計到2030年將達到255億美元，2024年至2030年期間的複合年成長率為21.5%。獨立組件和軟體是本報告分析的細分市場之一，預計其複合年成長率為20.2%，到分析期結束時規模將達到148億美元。整合設備細分市場在分析期間內的複合年成長率預計為23.4%。

美國市場預計將達到 21 億美元，中國市場複合年成長率將達到 20.4%

美國連網藥物輸送設備市場規模預計在2024年達到21億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到39億美元，在2024-2030年的分析期間內，複合年成長率為20.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為19.3%和18.4%。在歐洲，預計德國市場的複合年成長率約為14.7%。

全球連網藥物輸送設備市場－主要趨勢與促進因素摘要

什麼是連網藥物傳輸設備？為什麼它們會改變醫療保健？

連網藥物輸送設備是指配備感測器和連接功能的醫療設備，用於監測和管理藥物的給藥。這些設備包括智慧吸入器、胰島素筆、穿戴式注射器、自動注射器等，並即時向醫療服務提供者傳輸使用數據，從而深入了解患者的依從性和治療效果。連網藥物輸送設備可以提高患者依從性，提供個人化的用藥指導，並實現遠端患者監控。透過促進患者與醫療服務提供者之間的無縫溝通，這些設備正在改變醫療服務方式，確保患者獲得最有效、最個人化的照護。

連網藥物輸送設備的重要性在於它們能夠提高患者參與度和對處方方案的依從性，這對於管理糖尿病、氣喘和類風濕性關節炎等慢性疾病至關重要。這些設備收集的數據為醫療保健提供者提供了有關治療模式和患者行為的可行見解，從而能夠在出現依從性問題時進行主動干預。此外，連網型設備提供的即時回饋使患者用藥管理更加有效，降低了漏服和潛在併發症的風險。隨著醫療保健系統越來越注重以患者為中心、數據驅動的護理，連網藥物輸送設備在改善治療效果方面發揮關鍵作用。

科技進步如何改善連網藥物傳輸裝置？

技術進步正在迅速提升連網藥物傳輸設備的功能和應用，使其更加精準、患者友善且用途廣泛。藍牙、Wi-Fi 和近距離場通訊(NFC) 技術的整合，實現了資料從裝置到行動應用程式和雲端平台的無縫傳輸，使醫療專業人員能夠即時分析和存取資料。人工智慧和機器學習演算法也正在改變連網藥物輸送設備，使其能夠制定個人化的用藥方案，並根據患者行為預測依從性模式，從而改善整體治療效果。

穿戴式科技的發展催生了更舒適、更隱密的設備，例如智慧胰島素幫浦和穿戴式注射器，使患者能夠在最大程度上減少服藥對日常生活的干擾。此外，與行動應用程式的整合使患者能夠接收提醒、劑量追蹤和教育資源，從而鼓勵患者堅持服藥，並幫助患者主動管理自身病情。更長的電池壽命和更小的尺寸使這些設備更加便攜易用，滿足了活躍且移動性強的患者的需求。這些技術進步使聯網給藥設備成為現代醫療保健的重要組成部分，提高了患者的依從性、便利性和治療成功率。

連網藥物輸送設備在患者照護上的主要應用是什麼？

連網藥物傳輸設備正廣泛應用於慢性病管理領域，在這些領域，持續的服藥順從性至關重要。在糖尿病管理中，智慧胰島素筆和連續血糖監測儀 (CGM) 使患者能夠精準管理和追蹤胰島素劑量，提供數據支援個人化給藥，並降低併發症風險。在氣喘和慢性阻塞性肺病(COPD) 等呼吸系統疾病中，連網吸入器可提供吸入器使用情況的提醒和回饋，幫助患者遵守處方用藥方案，並允許醫護人員遠端監控病情控制情況。

在腫瘤學領域，穿戴式注射器可以控制化療藥物的輸送，減少患者頻繁就診的需要，並允許患者在家中管理治療。在類風濕性關節炎的治療中，連網自動注射器正被用於確保患者按處方接受藥物，並提供數據供醫護人員最佳化治療方案。在臨床試驗中，連網藥物傳輸設備透過收集精確的劑量資訊來提高數據準確性，減少對患者自我報告的依賴，並提高試驗的完整性。這些應用凸顯了連網藥物輸送設備在支援從疾病管理到臨床研究等患者照護各個方面的多功能性。

哪些因素推動了連網藥物輸送設備市場的成長？

連網藥物輸送設備市場的成長受到多種因素的推動，包括慢性病發病率的上升、連線健診技術的進步以及對患者依從性的日益重視。隨著糖尿病、氣喘和心血管疾病等慢性病的發生率不斷上升，連網藥物輸送設備的需求也隨之增加，因為它們在提高依從性和確保有效治療效果方面發揮著重要作用。人工智慧、行動應用整合和即時數據分析等技術進步增強了這些設備的功能，使其更易於使用，並能夠有效地進行遠端患者護理管理。

遠距遠端醫療和遠端患者監護日益普及，使醫療服務提供者能夠追蹤患者服藥依從性並在必要時進行干預，從而減少就診次數並提高病人參與。此外，對個人化醫療的日益關注也增加了對提供可客製化給藥方案和即時監控設備的需求，這與量身定做治療方案的趨勢一致。此外，製藥公司和醫療服務提供者意識到連網藥物輸送設備在臨床試驗中的優勢，這可以提高數據準確性和患者依從性。這些因素共同推動了連網藥物輸送設備市場的擴張，在日益數位化的醫療環境中，該市場在改善醫療服務和患者預後方面發揮著重要作用。

部分

產品（獨立組件和軟體、整合設備）；給藥途徑（腸胃外、吸入）；應用（糖尿病管理應用、慢性阻塞性肺病應用、氣喘應用、其他應用）

受訪公司範例

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP21524

Global Connected Drug Delivery Devices Market to Reach US$25.5 Billion by 2030

The global market for Connected Drug Delivery Devices estimated at US$7.9 Billion in the year 2024, is expected to reach US$25.5 Billion by 2030, growing at a CAGR of 21.5% over the analysis period 2024-2030. Standalone Components & Software, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Integrated Devices segment is estimated at 23.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 20.4% CAGR

The Connected Drug Delivery Devices market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 20.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.3% and 18.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Connected Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Connected Drug Delivery Devices, and Why Are They Transforming Healthcare?

Connected drug delivery devices are medical devices equipped with sensors and connectivity features that allow for the monitoring and management of drug administration. These devices include smart inhalers, insulin pens, wearable injectors, and auto-injectors that transmit real-time usage data to healthcare providers, offering insights into patient adherence and treatment efficacy. Connected drug delivery devices improve medication compliance, provide personalized dosage guidance, and enable remote patient monitoring, making them especially valuable in chronic disease management, where adherence to treatment is crucial for health outcomes. By facilitating seamless communication between patients and healthcare providers, these devices are transforming healthcare delivery, ensuring that patients receive the most effective, personalized care.

The significance of connected drug delivery devices lies in their ability to enhance patient engagement and adherence to prescribed regimens, which is vital in managing chronic conditions like diabetes, asthma, and rheumatoid arthritis. The data collected by these devices offers healthcare providers actionable insights into treatment patterns and patient behavior, enabling proactive intervention when adherence issues arise. Additionally, the real-time feedback provided by connected devices helps patients manage their medications more effectively, reducing the risk of missed doses and potential complications. As healthcare systems increasingly focus on patient-centered, data-driven care, connected drug delivery devices play a crucial role in improving treatment outcomes.

How Are Technological Advancements Enhancing Connected Drug Delivery Devices?

Technological advancements are rapidly improving the capabilities and applications of connected drug delivery devices, making them more precise, patient-friendly, and versatile. Integration of Bluetooth, Wi-Fi, and near-field communication (NFC) technologies allows for seamless data transfer from the device to mobile apps and cloud platforms, where data can be analyzed and accessed by healthcare providers in real time. AI and machine learning algorithms are also transforming connected drug delivery devices, enabling personalized medication schedules and predicting adherence patterns based on patient behavior, enhancing the overall treatment efficacy.

Advances in wearable technology have led to the development of more comfortable and discreet devices, such as smart insulin pumps and wearable injectors, that can deliver medication with minimal disruption to daily life. Furthermore, mobile app integration allows patients to receive reminders, dosage tracking, and educational resources, which promotes adherence and empowers patients to manage their conditions actively. Enhanced battery life and miniaturization have made these devices more portable and user-friendly, catering to the needs of active and mobile patients. Together, these technological advancements make connected drug delivery devices an integral part of modern healthcare, improving patient adherence, convenience, and treatment success.

What Are the Key Applications of Connected Drug Delivery Devices Across Patient Care?

Connected drug delivery devices are widely used across a range of chronic disease management applications, where consistent medication adherence is essential. In diabetes management, smart insulin pens and continuous glucose monitors (CGMs) allow patients to administer and track insulin doses accurately, providing data that supports personalized dosing and reduces the risk of complications. For respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), connected inhalers offer reminders and feedback on inhaler usage, helping patients adhere to prescribed regimens and enabling providers to monitor control of the condition remotely.

In the field of oncology, wearable injectors allow for controlled delivery of chemotherapy drugs, reducing the need for frequent hospital visits and enabling patients to manage their treatment at home. Connected auto-injectors are used in rheumatoid arthritis treatment, ensuring patients receive their medications as prescribed and providing data that healthcare providers can use to optimize treatment plans. In clinical trials, connected drug delivery devices improve data accuracy by capturing precise dosing information, reducing reliance on patient self-reporting and enhancing trial integrity. These applications underscore the versatility of connected drug delivery devices in supporting various aspects of patient care, from disease management to clinical research.

What Factors Are Driving Growth in the Connected Drug Delivery Devices Market?

The growth in the connected drug delivery devices market is driven by several factors, including the rise of chronic diseases, technological advancements in connected healthcare, and increasing emphasis on patient adherence. With the prevalence of chronic conditions like diabetes, asthma, and cardiovascular disease on the rise, connected drug delivery devices are in high demand for their role in improving adherence and ensuring effective treatment outcomes. Technological advancements, such as AI, mobile app integration, and real-time data analytics, are enhancing the capabilities of these devices, making them more user-friendly and effective in managing patient care remotely.

The growing acceptance of telemedicine and remote patient monitoring has further boosted adoption, as connected drug delivery devices allow healthcare providers to track adherence and intervene when necessary, reducing hospital visits and improving patient engagement. Increased focus on personalized medicine has also spurred demand for devices that offer customizable dosing schedules and real-time monitoring, aligning with the trend toward tailored treatment solutions. Moreover, pharmaceutical companies and healthcare providers are recognizing the benefits of connected drug delivery devices in clinical trials, where they improve data accuracy and patient compliance. Together, these factors are driving the expansion of the connected drug delivery devices market, supporting its role in enhancing healthcare delivery and patient outcomes in an increasingly digital healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Connected Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Standalone Components & Software, Integrated Devices); Administration Route (Parenteral Administration, Inhalational Administration); Application (Diabetes Management Application, COPD Application, Asthma Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Connected Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Drives Demand for Connected Drug Delivery Devices That Enable Remote Patient Monitoring
    • Growth in Home Healthcare Expands Market for Connected Drug Delivery Devices That Offer Self-Administration and Real-Time Feedback
    • Rising Focus on Personalized Medicine Propels Demand for Connected Devices That Provide Customizable Dosing and Monitoring
    • Advancements in IoT Technology Strengthen Business Case for Connected Drug Delivery Devices with Real-Time Data Sharing
    • Growing Demand for Patient Adherence Solutions Drives Adoption of Connected Drug Delivery Devices with Reminder and Tracking Features
    • Expansion of Digital Health Solutions Supports Market for Connected Devices That Integrate with Mobile Apps and Health Portals
    • Increasing Focus on Reducing Healthcare Costs Drives Demand for Connected Drug Delivery Devices That Minimize Hospital Visits
    • Rising Use of AI in Healthcare Expands Market for Connected Devices with Predictive Analytics and Personalized Care Features
    • Increasing Need for Continuous Glucose Monitoring Expands Market for Connected Drug Delivery Devices in Diabetes Management
    • Growing Focus on Remote Clinical Trials Drives Demand for Connected Drug Delivery Devices That Enable Real-Time Data Collection
    • Rising Investment in Smart Inhalers and Connected Injectors Propels Growth in Asthma and Respiratory Disease Management
    • Increasing Adoption of Wearable Health Tech Expands Applications of Connected Drug Delivery Devices in Chronic Disease Management
    • Growth in Preventive Healthcare Expands Market for Connected Devices That Monitor Patient Metrics and Predict Health Risks
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Standalone Components & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Standalone Components & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Integrated Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Integrated Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Inhalational Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Inhalational Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Diabetes Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Diabetes Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for COPD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for COPD Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Connected Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION